Cybercriminals’ tactics have evolved to target sensitive data and disrupt research and development in the pharmaceutical ...

Drugmakers are lobbying President Trump to phase in tariffs on imported pharmaceutical products to alleviate the impact and ...

As long as pharmaceutical tariffs are being considered, their potential threat to the pharmaceutical industry and the people ...

pharma companies too started foraying into the segment thereby offering third-party services in drug manufacturing. Now based on an analysis by EY-Parthenon, there are three major CDMO archetypes ...

Insurance companies in Mumbai anticipate a 15-20% hike in third-party motor insurance premiums from April 1 due to increasing claims and stagnant rates. With TP award inflation nearly at 12% annually ...

At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

An analysis by ING Bank suggests that proposed tariffs could increase the cost of certain cancer treatments by up to $10,000 ...

Jeddah – United Pharmacies Group has announced the signing of its first strategic agreement for the manufacturing of private-label pharmaceutical and therapeutic products in partnership with Avalon ...

Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for ...